These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29625707)

  • 1. [Atropinic burden and anticholinergic drugs: Interest and application in clinical practice in the elderly].
    de Germay S; Lapeyre-Mestre M; Montastruc JL; Montastruc F
    Therapie; 2021; 76(6):665-673. PubMed ID: 29625707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure to atropinic drugs and frailty status.
    Moulis F; Moulis G; Balardy L; Gérard S; Montastruc F; Sourdet S; Rougé-Bugat ME; Lapeyre-Mestre M; Montastruc JL; Rolland Y; Vellas B
    J Am Med Dir Assoc; 2015 Mar; 16(3):253-7. PubMed ID: 25548029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atropinic (anticholinergic) burden in antipsychotic-treated patients.
    Montastruc F; Benevent J; Touafchia A; Chebane L; Araujo M; Guitton-Bondon E; Durrieu G; Arbus C; Schmitt L; Begaud B; Montastruc JL
    Fundam Clin Pharmacol; 2018 Feb; 32(1):114-119. PubMed ID: 28887902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends of atropinic (anticholinergic) exposure in the elderly: a 10-year analysis in the French EGB database.
    de Germay S; Rueter M; Montastruc F; Rousseau V; Lapeyre-Mestre M; Montastruc JL
    Fundam Clin Pharmacol; 2019 Aug; 33(4):471-478. PubMed ID: 30687946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anticholinergic scales: Use in psychiatry and update of the anticholinergic impregnation scale].
    Javelot H; Meyer G; Becker G; Post G; Runge V; Pospieszynski P; Schneiderlin T; Armand-Branger S; Michel B; Weiner L; Faria CGF; Drapier D; Fakra E; Fossati P; Haffen E; Yrondi A; Hingray C
    Encephale; 2022 Jun; 48(3):313-324. PubMed ID: 34876278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anticholinergic impregnation scale: Towards the elaboration of a scale adapted to prescriptions in French psychiatric settings.
    Briet J; Javelot H; Heitzmann E; Weiner L; Lameira C; D'Athis P; Corneloup M; Vailleau JL
    Therapie; 2017 Sep; 72(4):427-437. PubMed ID: 28336159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher intake of medications for digestive disorders in children prenatally exposed to drugs with atropinic properties.
    Benevent J; Hurault-Delarue C; Araujo M; Montastruc F; Montastruc JL; Lacroix I; Damase-Michel C
    Fundam Clin Pharmacol; 2019 Jun; 33(3):314-326. PubMed ID: 30365180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atropinic burden of prescriptions forms in patients with Alzheimer disease: a cross-sectional study in a French PharmacoVigilance Database.
    Montastruc F; Rouanet S; Gardette V; Rousseau V; Bagheri H; Montastruc JL
    Eur J Clin Pharmacol; 2015 Jul; 71(7):891-5. PubMed ID: 25991052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atropinic (Anticholinergic) Burden in Parkinson's Disease.
    De Germay S; Montastruc JL; Rousseau V; Chebane L; Bondon-Guitton E; Moulis F; Durrieu G; Bagheri H; Rascol O; Pariente A; Bégaud B; Montastruc F
    Mov Disord; 2016 May; 31(5):632-6. PubMed ID: 27028036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review.
    Andre L; Gallini A; Montastruc F; Montastruc JL; Piau A; Lapeyre-Mestre M; Gardette V
    Eur J Clin Pharmacol; 2019 Dec; 75(12):1631-1644. PubMed ID: 31468067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study.
    Weichert I; Romero-Ortuno R; Tolonen J; Soe T; Lebus C; Choudhury S; Nadarajah CV; Nanayakkara P; Orrù M; Di Somma S;
    J Clin Pharm Ther; 2018 Oct; 43(5):682-694. PubMed ID: 29729025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study.
    Andre L; Gallini A; Montastruc F; Coley N; Montastruc JL; Vellas B; Andrieu S; Gardette V;
    Br J Clin Pharmacol; 2019 Jan; 85(1):71-99. PubMed ID: 30098049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An anticholinergic burden score for German prescribers: score development.
    Kiesel EK; Hopf YM; Drey M
    BMC Geriatr; 2018 Oct; 18(1):239. PubMed ID: 30305048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A High Postoperative Atropinic Burden is Associated with Postoperative Delirium in Elderly Patients with Hip Fracture: Results of the Prospective, Observational, ATROPAGE Trial.
    Ferré F; Piel-Julian ML; Tincres F; Ba C; Menut R; Ferrier A; Bosch L; Martin C; Labaste F; Montastruc F; Sommet A; Balardy L; Minville V
    Clin Interv Aging; 2022; 17():1931-1938. PubMed ID: 36605703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden.
    Green AR; Reifler LM; Boyd CM; Weffald LA; Bayliss EA
    Drugs Aging; 2018 Mar; 35(3):223-232. PubMed ID: 29404965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticholinergic drug burden according to the anticholinergic drug scale and the German anticholinergic burden and their impact on cognitive function in multimorbid elderly German people: a multicentre observational study.
    Krüger C; Schäfer I; van den Bussche H; Bickel H; Fuchs A; Gensichen J; König HH; Maier W; Mergenthal K; Riedel-Heller SG; Schön G; Weyerer S; Wiese B; von Renteln-Kruse W; Langebrake C; Scherer M
    BMJ Open; 2021 Mar; 11(3):e044230. PubMed ID: 33757948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atropinic burden of drugs during pregnancy and psychological development of children: a cohort study in the EFEMERIS database.
    Beau AB; Montastruc JL; Lacroix I; Montastruc F; Hurault-Delarue C; Damase-Michel C
    Br J Clin Pharmacol; 2016 Aug; 82(2):478-86. PubMed ID: 27085086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study.
    Green AR; Reifler LM; Bayliss EA; Weffald LA; Boyd CM
    Drugs Aging; 2019 Mar; 36(3):289-297. PubMed ID: 30652263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study.
    Pasina L; Djade CD; Lucca U; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Violi F; Mannucci PM
    Drugs Aging; 2013 Feb; 30(2):103-12. PubMed ID: 23239364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of the Swedish anticholinergic burden scale (Swe-ABS).
    Rube T; Ecorcheville A; Londos E; Modig S; Johansson P
    BMC Geriatr; 2023 Aug; 23(1):518. PubMed ID: 37626293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.